CASI NORMAN: Open Payments
NPI 1205369121 · BROWNSBURG, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,029 in 33 payments from 7 companies in 2025. Trend: 2023 $1,561 · 2024 $449 · 2025 $1,029
Food & beverage: $1,029
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $306 |
| ABBVIE INC. | 10 | $268 |
| Astellas Pharma US Inc | 7 | $191 |
| Amneal Pharmaceuticals LLC | 8 | $142 |
| SHIELD THERAPEUTICS INC | 3 | $87 |
| MERZ NORTH AMERICA, INC. | 1 | $19 |
| Acella Pharmaceuticals, LLC | 1 | $17 |
Products named: TREMFYA, Veozah, QULIPTA, UNITHROID, ACCRUFER, BOTOX, Xeomin, NP Thyroid 60.
Industry payments across IN — which companies pay providers there.
